The importance of pharmacokinetic studies in drug development

被引：4
|
作者：
Archer, David F. [1 ]
机构：
[1] Eastern Virginia Med Sch, Jones Inst Reprod Med, Norfolk, VA 23507 USA
来源：
CONTRACEPTION | 2013年 / 87卷 / 06期
关键词：
RANDOMIZED-CONTROLLED-TRIAL; NORMAL-WEIGHT; WOMEN; CONTRACEPTION; PROGESTINS; OBESE;
D O I：
10.1016/j.contraception.2013.04.004
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：701 / 702
页数：2
相关论文
共 50 条
  • [1] THE IMPORTANCE OF PHARMACOKINETIC AND RECEPTOR STUDIES IN DRUG SAFETY EVALUATION
    EASON, CT
    BONNER, FW
    PARKE, DV
    REGULATORY TOXICOLOGY AND PHARMACOLOGY, 1990, 11 (03) : 288 - 307
  • [2] IMPORTANCE OF ANALYTICAL METHODS IN PHARMACOKINETIC AND DRUG-METABOLISM STUDIES
    HIRTZ, J
    BIOPHARMACEUTICS & DRUG DISPOSITION, 1986, 7 (04) : 315 - 326
  • [3] Pharmacokinetic/pharmacodynamic studies in drug product development
    Meibohm, B
    Derendorf, H
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2002, 91 (01) : 18 - 31
  • [4] Preface - Importance of pharmacokinetic considerations in the development of drug delivery systems
    Sugiyama, Y
    ADVANCED DRUG DELIVERY REVIEWS, 1996, 19 (03) : 333 - 334
  • [5] The importance of pharmacokinetic limited sampling models for childhood cancer drug development
    Panetta, JC
    Iacono, LC
    Adamson, PC
    Stewart, CF
    CLINICAL CANCER RESEARCH, 2003, 9 (14) : 5068 - 5077
  • [6] Development of drugs with ideal pharmacokinetic profiles - importance of drug transporter research
    Sugiyama, Y
    JAPANESE JOURNAL OF PHARMACOLOGY, 2002, 88 : 8P - 8P
  • [7] A Survey of Neonatal Pharmacokinetic and Pharmacodynamic Studies in Pediatric Drug Development
    Wang, J.
    Avant, D.
    Green, D.
    Seo, S.
    Fisher, J.
    Mulberg, A. E.
    McCune, S. K.
    Burckart, G. J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2015, 98 (03) : 328 - 335
  • [8] Development of gene drug delivery systems based on pharmacokinetic studies
    Takakura, Y
    Nishikawa, M
    Yamashita, F
    Hashida, M
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2001, 13 (01) : 71 - 76
  • [9] Pharmacokinetic–Pharmacodynamic Modeling in Pediatric Drug Development, and the Importance of Standardized Scaling of Clearance
    Eva Germovsek
    Charlotte I. S. Barker
    Mike Sharland
    Joseph F. Standing
    Clinical Pharmacokinetics, 2019, 58 : 39 - 52
  • [10] Importance of the Studies on the Drug Actions to the Mitochondria for the Future Drug Development Foreword
    Shinohara, Yasuo
    Ohkura, Kazuto
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2012, 132 (10): : 1091 - 1092
12345